Cargando…
Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes
BACKGROUND: We evaluated the risks of renal and cardiovascular complications, and mortality associated with lower extremity amputation (LEA) in patients with type 1 diabetes. METHODS: We studied two cohorts of people with long standing type 1 diabetes: GENEDIAB (n = 456) and GENESIS (n = 611). Subse...
Autores principales: | Mohammedi, Kamel, Potier, Louis, Belhatem, Narimène, Matallah, Nadia, Hadjadj, Samy, Roussel, Ronan, Marre, Michel, Velho, Gilberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705699/ https://www.ncbi.nlm.nih.gov/pubmed/26743116 http://dx.doi.org/10.1186/s12933-015-0322-0 |
Ejemplares similares
-
Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes
por: Camoin, Marion, et al.
Publicado: (2022) -
Redox Genetic Risk Score and the Incidence of End-Stage Kidney Disease in People with Type 1 Diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2022) -
Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
por: Velho, Gilberto, et al.
Publicado: (2018) -
Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
por: Velho, Gilberto, et al.
Publicado: (2013) -
SGLT2 inhibitors and lower limb complications: the diuretic-induced hypovolemia hypothesis
por: Potier, Louis, et al.
Publicado: (2021)